跳至主要内容
临床试验/PACTR202002753354517
PACTR202002753354517尚未招募3 期

Impact of mobile technologies on cervical cancer screening practices in Lagos, Nigeria: A randomised controlled trial mHealth-Cervix

College of Medicine University of Lagos0 个研究点目标入组 200 人开始时间: 2020年2月13日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • NHIS enrollees
  • Aged between 25 and 65 years
  • No prior history of cervical cancer or cervical dysplasia
  • Those not adherent with current recommendations for Pap smear screening (have not had a Pap smear within the last three years)
  • Those owning and using a personal cellphone
  • Those free from any mental or physical disabilities that inhibit them from understanding the implications of the study
  • Those not considering relocating from their current residence within the next year.

排除标准

  • Women younger than 25 and older than 65 years old,
  • Those with history of cervical dysplasia and cancer
  • Those who had a Pap test within the last three years
  • Those with an ongoing pregnancy
  • Those who refuse or withdraw consent during the course of the study.

研究者

相似试验